These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3308718)

  • 1. A preliminary pharmacokinetic study of cyclosporine A in 10 Japanese renal transplant patients.
    Takada K; Yoshikawa H; Muranishi S; Nagano S; Fukunishi T
    Int J Clin Pharmacol Ther Toxicol; 1987 Aug; 25(8):438-42. PubMed ID: 3308718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Marked interspecies differences between humans and pigs in cyclosporine and prednisolone disposition.
    Frey BM; Sieber M; Mettler D; Gänger H; Frey FJ
    Drug Metab Dispos; 1988; 16(2):285-9. PubMed ID: 2898348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of plasma lipid on pharmacokinetics of ciclosporin and its relationship with plasma prednisolone level in renal transplant patients.
    Sugioka N; Kokuhu T; Okamoto M; Yoshimura N; Ito Y; Shibata N; Takada K
    J Pharm Pharmacol; 2006 Sep; 58(9):1193-200. PubMed ID: 16945177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence of different pharmacokinetics between cyclosporine and tacrolimus in renal transplant recipients: why cyclosporine is monitored by C2 level and tacrolimus by trough level.
    Takeuchi H; Matsuno N; Hirano T; Toraishi T; Konno O; Nakamura Y; Iwamoto H; Hama K; Unezaki S; Nagao T
    Transplant Proc; 2008 Sep; 40(7):2240-2. PubMed ID: 18790203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of appropriate blood level in continuous intravenous infusion from trough concentrations after oral administration based on area under trough level in tacrolimus and cyclosporine therapy.
    Nakamura Y; Takeuchi H; Okuyama K; Akashi T; Jojima Y; Konno O; Akashi I; Hama K; Iwahori T; Ashizawa T; Hirano T; Oka K; Matsuno N; Nagao T
    Transplant Proc; 2005 May; 37(4):1725-7. PubMed ID: 15919445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal dose and target trough level in cyclosporine and tacrolimus conversion in renal transplantation as evaluated by lymphocyte drug sensitivity and pharmacokinetic parameters.
    Takeuchi H; Okuyama K; Konno O; Jojima Y; Akashi I; Nakamura Y; Iwamoto H; Hama K; Iwahori T; Uchiyama M; Ashizawa T; Matsuno N; Nagao T; Hirano T; Oka K
    Transplant Proc; 2005 May; 37(4):1745-7. PubMed ID: 15919452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Nyctohemeral variations of cyclosporine administered orally in renal transplant patients].
    Ramon M; Morel D; Penouil F; Grellet J; Potaux L; Saux MC; Brachet-Liermain A
    Therapie; 1989; 44(5):371-4. PubMed ID: 2814916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of initial i.v. CYA dosage to achieve target AUC values in pediatric hematopoietic stem cell transplant patients.
    Jin M; Seto W; Taylor T; Saunders EF; Doyle J; Dupuis LL
    Bone Marrow Transplant; 2008 Oct; 42(7):455-9. PubMed ID: 18622423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The area under the concentration-time curve versus trough and peak blood level monitoring in renal transplant recipients on cyclosporine.
    Halim MA; Nampoory MR; Johny KV; Donia F; Hamid MH; Said T; Nair MP; Mansour M; Al-Muzairai I; Samhan M; Al-Mousawi M
    Transplant Proc; 2005 Sep; 37(7):3019-21. PubMed ID: 16213291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacokinetic of cyclosporin A].
    Bourdat-Michel G; Dechelette E; Serre-Debeauvais F; Bost M; Beaudoing A
    Pediatrie; 1990; 45(9):571-5. PubMed ID: 2175417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of oral cyclosporine (Neoral) in heart transplant recipients during the immediate period after surgery.
    Banner NR; David OJ; Leaver N; Davis J; Breen J; Johnston A; Yacoub MH
    Transpl Int; 2002 Dec; 15(12):649-54. PubMed ID: 12478413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Oral cyclosporine pharmacokinetics in renal transplantation patients].
    Zhuo HT; Chen G
    Yao Xue Xue Bao; 1990; 25(1):1-5. PubMed ID: 2363351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclosporine monitoring in renal transplantation: area under the curve monitoring is superior to trough-level monitoring.
    Grevel J; Welsh MS; Kahan BD
    Ther Drug Monit; 1989; 11(3):246-8. PubMed ID: 2658210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of pharmacokinetic profiles in 232 renal and 87 cardiac allograft recipients treated with cyclosporine.
    Kahan BD; Kramer WG; Wideman CA; Frazier OH; Lorber MI; Williams C; Flechner SM; Cooley DA; Van Buren CT
    Transplant Proc; 1986 Dec; 18(6 Suppl 5):115-9. PubMed ID: 3538563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term comparative results of C0 and C2 monitoring of CyA in renal transplanted patients.
    Paydaş S; Balal M; Sertdemir Y; Seyrek N; Karayaylali I
    Ren Fail; 2005; 27(4):409-13. PubMed ID: 16060128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C2 is an age-independent parameter for optimal cyclosporine exposure in long-term kidney transplant recipients.
    Ferraresso M; Citterio F; Ghio L; Romagnoli J; Edefonti A; Berardinelli L; Castagneto M
    Transplant Proc; 2004 Nov; 36(9):2656-8. PubMed ID: 15621115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal assessment of everolimus in de novo renal transplant recipients over the first post-transplant year: pharmacokinetics, exposure-response relationships, and influence on cyclosporine.
    Kovarik JM; Kahan BD; Kaplan B; Lorber M; Winkler M; Rouilly M; Gerbeau C; Cambon N; Boger R; Rordorf C;
    Clin Pharmacol Ther; 2001 Jan; 69(1):48-56. PubMed ID: 11180038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between area under the concentration versus time curve of cyclosporin A, creatinine clearance, hematocrit value, and other clinical factors in Japanese renal transplant patients.
    Shibata N; Hoshino N; Minouchi T; Yamaji A; Park K; Tomoyoshi T; Abe H; Kodama M
    Int J Clin Pharmacol Ther; 1998 Apr; 36(4):202-9. PubMed ID: 9587046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dosage of Cyclosporin A in children with renal transplants.
    Hoyer PF; Offner G; Wonigeit K; Brodehl J; Pichlmayr R
    Clin Nephrol; 1984 Aug; 22(2):68-71. PubMed ID: 6383673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclosporin-erythromycin interaction in normal subjects.
    Freeman DJ; Martell R; Carruthers SG; Heinrichs D; Keown PA; Stiller CR
    Br J Clin Pharmacol; 1987 Jun; 23(6):776-8. PubMed ID: 3606938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.